Below are the most recent publications written about "Ocular Hypertension" by people in Profiles.
-
Leshno A, Bommakanti N, De Moraes CG, Gordon MO, Kass MA, Cioffi GA, Liebmann JM. Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc. Eye (Lond). 2024 Jun; 38(8):1549-1555.
-
Diamond DF, Hirji S, Xing SX, Gorroochurn P, Horowitz JD, Wang Q, Park L, Harizman N, Maruri SC, Henriquez DR, Liebmann JM, Cioffi GA, Hark LA. Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT): optometric exam improves access and utilization of eye care services. Graefes Arch Clin Exp Ophthalmol. 2024 May; 262(5):1619-1631.
-
Abbasi A, Antony BJ, Gowrisankaran S, Wollstein G, Schuman JS, Ishikawa H. Can Glaucoma Suspect Data Help to Improve the Performance of Glaucoma Diagnosis? Transl Vis Sci Technol. 2023 08 01; 12(8):6.
-
Fanton FL, Picetti E, Rodrigues SF, Moreira TS, Lindenmeyer RL, Lavinsky F, Pakter HM. Glaucoma suspects referred by general ophthalmologists to a tertiary center in Brazil: outcomes of the glaucoma specialist assessment. Arq Bras Oftalmol. 2023 May-Jun; 86(3):248-254.
-
Madu CT, Phelps T, Schuman JS, Zambrano R, Lee TF, Panarelli J, Al-Aswad L, Wollstein G. Automated 360-degree goniophotography with the NIDEK Gonioscope GS-1 for glaucoma. PLoS One. 2023; 18(3):e0270941.
-
Wakabayashi T, Liu CK, Anderson HE, Mahmoudzadeh R, Nguyen MK, Salabati M, Chiang A, Hsu J, Garg SJ, Spirn MJ. A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes. Ophthalmol Retina. 2023 06; 7(6):480-488.
-
Wong JC, Shiuey EJ, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Pro MJ, Lee D. The effectiveness and tolerability of fixed-dose combination netarsudil 0.02%/latanoprost 0.005% at a tertiary glaucoma center. Graefes Arch Clin Exp Ophthalmol. 2023 Jan; 261(1):193-200.
-
McDowell CM, Kizhatil K, Elliott MH, Overby DR, van Batenburg-Sherwood J, Millar JC, Kuehn MH, Zode G, Acott TS, Anderson MG, Bhattacharya SK, Bertrand JA, Borras T, Bovenkamp DE, Cheng L, Danias J, De Ieso ML, Du Y, Faralli JA, Fuchshofer R, Ganapathy PS, Gong H, Herberg S, Hernandez H, Humphries P, John SWM, Kaufman PL, Keller KE, Kelley MJ, Kelly RA, Krizaj D, Kumar A, Leonard BC, Lieberman RL, Liton P, Liu Y, Liu KC, Lopez NN, Mao W, Mavlyutov T, McDonnell F, McLellan GJ, Mzyk P, Nartey A, Pasquale LR, Patel GC, Pattabiraman PP, Peters DM, Raghunathan V, Rao PV, Rayana N, Raychaudhuri U, Reina-Torres E, Ren R, Rhee D, Chowdhury UR, Samples JR, Samples EG, Sharif N, Schuman JS, Sheffield VC, Stevenson CH, Soundararajan A, Subramanian P, Sugali CK, Sun Y, Toris CB, Torrejon KY, Vahabikashi A, Vranka JA, Wang T, Willoughby CE, Xin C, Yun H, Zhang HF, Fautsch MP, Tamm ER, Clark AF, Ethier CR, Stamer WD. Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms. Invest Ophthalmol Vis Sci. 2022 02 01; 63(2):12.
-
Zhu Z, Waxman S, Wang B, Wallace J, Schmitt SE, Tyler-Kabara E, Ishikawa H, Schuman JS, Smith MA, Wollstein G, Sigal IA. Interplay between intraocular and intracranial pressure effects on the optic nerve head in vivo. Exp Eye Res. 2021 12; 213:108809.
-
Shiuey EJ, Mehran NA, Ustaoglu M, Zhang Q, Razeghinejad R, Shukla AG, Kolomeyer NN, Myers JS, Lee D. The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes. Graefes Arch Clin Exp Ophthalmol. 2022 Mar; 260(3):967-974.